Abstract
Putative biological functions of lysosomal cysteine peptidases especially of cathepsins B and L in tumour progression have recently been considered in several reviews and the respective literature has been compiled1–5. Here, only some aspects of the extracellular and intracellular functions of these enzymes and the correlation of expression of cathepsins L and H with the malignancy of tumours should be discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
L Kane, S.E., and Gottesman, M.M., 1990, The role of cathepsin L in malig nant transformation, Semin. Cancer Biol. I: 127–136.
Sloane, B.F., Moin, K., Krepela, E., and Rozhin, J., 1990, Cathepsin B and its endogenous inhibitors: the role in tumor malignancy, Cancer Metast. Rev. 9: 333–352.
Gottesman, M.M., 1993, Cathepsin L and cancer, in: Proteolysis and Protein Turnover, Bond, J.S., and Barrett, A.J., eds., Portland Press, London and Chapel Hill, 247–251.
Berquin, I.M., and Sloane, B.F., 1996, Cathepsin B expression in human tumors, in: Intracellular Protein Catabolism, Suzuki, K., and Bond, J.S., eds., Plenum Press, New York and London, 281–294.
Kirschke, H., Barrett, A.J., and Rawlings, N.D., 1995, Proteinases 1: Lyso somal cysteine proteinases, Protein Profile 2: 1587–1643.
Schmitt, M., Goretzki, L., Jänicke, F., Calvete, J., Eulitz, M., Kobayashi, H., Chucholowski, N., and Graeff, H., 1991, Biological and clinical relevance of the urokinase-type plasminogen activator (uPA) in breast cancer, Biomed. Biochim. Acta 50: 731–741.
McCoy, K., Gal, S., Schwartz, R.H., and Gottesman, M.M., 1988, An acid protease secreted by transformed cells interferes with antigen processing, J. Cell Blot. 106: 1879–1884.
Kasai, M., Shirasawa, T., Kitamura, M., Ishido, K., Kominami, E., and Hi-rokawa, K., 1993, Proenzyme form of cathepsin L produced by thymic epi thelial cells promotes proliferation of immature thymocytes in the presence of IL-1, IL-7, and anti-CD3 antibody, Cell. Immunol. 150: 124–136.
Weber, E., Günther, D., Laube, F., Wiederanders, B., and Kirschke, H.. 1994, Hybridoma cells producing antibodies to cathepsin L have greatly reduced potential for tumour growth, J. Cancer Res. Clin. Oncol. 120: 564–567.
Homma, K., Kurata, S.. and Natori, S., 1994, Purification, characterization, and cDNA cloning of procathepsin L from the culture medium of NIH-Sape- 4, an embryonic cell line of Sarcophaga peregrino (flesh fly), and its invol vement in the differentiation of imaginal discs,. 1. Biol. Chem. 269: 15258–15264.
Dehrmann, F.M., Coetzer, T.H.T., Pike, R.N., and Dennison, C., 1995, Ma turc cathepsin L is substantially active in the ionic milieu of the extracellular medium, Arch. Biochem. Biophy.s. 324: 93–98.
Turk. B., Dolenc, I., Turk, V., and Bieth, J.G., 1993, Kinetics of the pH-indu ced inactivation of human cathepsin L, Biochemistry 32: 375–380.
Brix, K.. Lemansky, P., and Herzog, V., 1996, Evidence for extracellularly acting cathepsins mediating thyroid hormone liberation in thyroid epithelial cells, Endocrinology 137: 1963–1974.
Rozhin, J.. Sameni, M., Ziegler, G., and Sloane, B.F.. 1994, Pericellular pH affects distribution and secretion of cathepsin B in malignant cells, Cancer Res. 54 6517–6525.
Ebert, W., Werle, B., Ebert, E., Kos, J., Lah, T., and Abrahamson, M., 1996, Cathepsins and cystatins. prognostic factors in human lung cancer, 11th International Conference on Proteolysis and Protein Turnover: Turku (Poster Abstract N°132).
Scaddan, P.B., and Dufresne, M.J., 1993, Characterization of cysteine pro teases and their endogenous inhibitors in MCF-7 and adriamycin-resistant MCF-7 human breast cancer cells, Invar. Metast. 13: 301 313.
Sheahan, K., Shuja. S.. and Murnane, M.J., 1989, Cysteine protease ac tivities and tumor development in human colorectal carcinoma. Cancer Res. 49: 3809–3814.
Adenis, A., Huet. G., Zerimech. F., Hecquet, B., Balduyck, M., and Peyrat, J.P., 1995, Cathepsin B. L, and D activities in colorectal carcinomas: rela tionship with clinico-pathological parameters, Cancer Lett. 96: 267–275.
Rozhin,.1., Wade. R.L., Bonn. K.V., and Sloane, B.F., 1989, Membrane-as-sociated cathepsin L: a role in metastasis of melanomas, Biochem. Biophys. Res. Commun. 164: 556–561.
Qian, F., Bajkowski, A.S., Steiner, D.F., Chan, S.J., and Frankfater, A., 1989, Expression of five cathepsins in murine melanomas of varying metas tatic potential and normal tissues, Cancer Res. 49: 4870–4875.
Kageshita, T., Yoshi i, A., Kimura, T., Maruo, K., Ono, T., Himeno, M.. and Nishimura, Y., 1995, Biochemical and immunohistochemical analysis of cathepsins B, H, L and D in human melanocytic tumours,. Arch. Dermatol. Res. 287: 266–272.
Sivaparvathi, M., Yamamoto, M., Nicolson, G.L., Gokaslan, Z.L., Fuller, G.N., Liotta, L.A., Sawaya, R., and Rao, J.S., 1996, Expression and immu nohistochemical localization of cathepsin L during the progression of human gliomas. Clin. Exp. Metast. 14: 27–34.
Denhardt, D.T., Greenberg, A.H.. Egan, S.E., Hamilton, R.T., and Wright, J.A., 1987, Cysteine proteinase cathepsin L expression correlates closely with the metastatic potential of H-ras-transformed murine fibroblasts, On cogene 2: 55–59.
Chambers, A.F., Colella, R., Denhardt, D.T., and Wilson, S.M., 1992, In-creased expression of cathepsins L and B and decreased activity of their in hibitors in metastatic, ras-transformed NIH 3T3 cells, Mol. Carcinog. 5: 238–245.
Sivaparvathi, M., Sawaya, R., Gokaslan, Z.L., Chintala, K.S., and Rao, J.S., 1996, Expression and the role of cathepsin H in human glioma progression and invasion, Cancer Lett. 104: 121–126.
Gabrijeléié, D., Svetic, B., Spaié, D., Skrk, J., Budihna, M., Dolenc, I., Po povié, T., Cotié, V., and Turk, V., 1992, Cathepsins B, H and L in human breast carcinoma, Eue J. Clin. Chem. Clin. Biochem. 30: 69–74.
Murnane, M.J., Cai, J., Shuja, S., Coté, L., Del Re, E., lacobuzio-Donahue, C., Kim, K., and Sheahan, K., 1995, Changing patterns of proteolytic ex pression with colorectal tumor progression, in: Proteases Involved in Cancer, Suzuki, M., and Hiwasa, T., eds., Monduzzi Editore, Bologna, 11–26.
Yagel, S., Warner, A.H., Nellans, H.N., Lala, P.K., Waghorne, C., and Den hardt, D.T., 1989, Suppression by cathepsin L inhibitors of the invasion of amnion membranes by murine cancer cells, Cancer Res. 49: 3553–3557.
Bond, J. S., and A. J. Barrett, 1993, Proteolysis and protein turnover, Proceeding of the 9th I(.’OP Meeting. Williamsburg, Virginia, U. S. A., Portland Press Proceedings. page X IV.
Hoesch, Kurt, 1921, Emil Fischer. sein Leben und sein Werk, Verlag Chemie, G.m.b.11.. Berlin und Leipzig, 480 pages.
Abderhalden. Emil. 1906. Lehrbuch der Physiologischen Chemie, Urbahn und Schwarzenberg, Berlin. Wien, 787 pages.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kirschke, H. (1997). Lysosomal Cysteine Peptidases and Malignant Tumours. In: Ansorge, S., Langner, J. (eds) Cellular Peptidases in Immune Functions and Diseases. Advances in Experimental Medicine and Biology, vol 421. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9613-1_33
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9613-1_33
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9615-5
Online ISBN: 978-1-4757-9613-1
eBook Packages: Springer Book Archive